Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Nov 5, 2024
Product Development
Arcus data the latest twist in the TIGIT story
BioCentury’s Clinical Report also analyzes the impact of a patient death in Beam’s trial, plus data from Cogent, Disc, Essa and Novo
BioCentury | Jun 10, 2022
Product Development
Cogent’s first clinical readout in systemic mastocytosis drives stock bump
Ex-Array team believes in-licensed therapy can be best-in-class in hematological disorder
BioCentury | Oct 11, 2019
Preclinical News
Oct. 10 Preclinical Quick Takes: Merck-Prokaryotics Inc.-Princeton ID new antibiotic class; plus NIH, Owkin, Genentech and ICR
BioCentury | Dec 15, 2017
Clinical News
Blueprint reports Phase I data for avapritinib in systemic mastocytosis
Items per page:
1 - 10 of 76